相关实验视频
Updated: May 21, 2025
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
8.6K
中国的多发性硬化症:诊断和管理的现状
Dongmei Jia1, Fu-Dong Shi1,2, Wei Jiang1
1Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin.
Current opinion in neurology
|March 19, 2025
概括
中国的多发性硬化症 (MS) 是一个日益严重的公共卫生问题. 诊断和治疗方面的进步,以及中国国家注册局等正在进行的研究,正在改善患者管理.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 多发性硬化症 (MS) 患病率在中国正在上升,这对公众健康构成了重大挑战.
- 城市和农村地区之间存在差异,影响了MS患者的护理.
- 在中国,MS的临床表现因人口和环境因素而异.
研究的目的:
- 提供关于中国多发性硬化症 (MS) 最近进展的全面概述.
- 讨论诊断和治疗的挑战和未来的研究方向.
- 突出卫生政策在MS管理中的作用.
主要方法:
- 关于中国MS诊断和治疗近期进展的文献综述.
- 对诊断工具的分析,包括7T核磁共振,核磁共振.
- 检查疾病修饰疗法和医疗保健政策.
主要成果:
- 通过先进的成像技术提高诊断精度,如7T MRI.
- 增加疾病修饰剂的可用性和医疗政策支持的更广泛的治疗选择.
- 目前正在进行的研究,包括中国国家神经炎症疾病注册研究 (NCT05154370),对于未来的进展至关重要.
结论:
- 在中国,多发性硬化症的识别和管理得到了改善,诊断更快,治疗选择更多.
- 研究举措和大规模的队列研究正在中国MS领域取得重大进展.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
52
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
52
01:20Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K